- Fee assured
- Awaiting verification
I have been a consultant rheumatologist since 2009 having completed my rheumatology training in Oxford. During my time in Oxford, I also did research culminating in a higher degree from the University of Oxford. I run a highly efficient rheumatology service at the Norfolk and Norwich University Hospital as part of which I have conducted over 10000 consultations.
I am an opinion leader in rheumatology having authored several scientific papers, reviews and book chapters.
I serve on national and international committees relating to policy-making in rheumatology and education and professional examinations.
Areas of interest
General rheumatology; Inflammatory arthritis; Giant cell arteritis; Ultrasound in diagnosis of giant cell arteritis; ANCA associated vasculitis; Systemic vasculitis
- My personal webpage: https://sites.google.com/site/chetmukh/
- My profile on the Norfolk and Norwich University Hospital website: http://www.nnuh.nhs.uk/Person.asp?id=425
- My specialistinfo page: http://www.specialistinfo.com/consget.php?con=mukhrheu01
- My Linked In page: https://www.linkedin.com/pub/chetan-mukhtyar/92/b09/304
Current NHS consultant posts held
I have been a consultant in rheumatology at the Norfolk and Norwich University Hospital since March 2009.
I have a research interest in the treatment of ANCA associated vasculitis, having participated in clinical trials and analysing the data. I have also authored the seminal European guidelines for the management of systemic vasculitis. My research interest in outcome measures in rheumatology focuses on identifying better ways of measuring improvement and change in rheumatic conditions. This interest has resulted in several scientific publications.
I enjoy following Formula 1, and I love playing chess.
Clinical Excellance Award - Level 2
(Additional) Languages spoken
Revising DAS28 scores for remission in rheumatoid arthritis. Clin Rheumatol. 2014 Feb;33(2):269-72.
Standardized grip strength as an outcome measure in early rheumatoid arthritis. Scand J Rheumatol. 2013;42(4):289-93.
Disseminated Mycobacterium avium infection masquerading as longstanding polymyositis. JRSM Short Rep. 2011 Dec;2(12):94.
Isolated large vessel pulmonary vasculitis as a cause of chronic obstruction of the pulmonary arteries. Pulm Circ. 2011 Jul-Sep;1(3):425-9.
A model to predict cardiovascular events in patients with newly diagnosed Wegener's granulomatosis and microscopic polyangiitis. Arthritis Care Res (Hoboken). 2011 Apr;63(4):588-96.
Health-related quality of life in patients with newly diagnosed antineutrophil cytoplasmic antibody-associated vasculitis. Arthritis Care Res (Hoboken). 2011 Jul;63(7):1055-61.
A cross-sectional study of the Birmingham
Vasculitis Activity Score version 3 in systemic vasculitis. Rheumatology (Oxford). 2011 May;50(5):899-905.
Long-term patient survival in ANCA-associated vasculitis. Ann Rheum Dis. 2011 Mar;70(3):488-94.
Long-term damage to the ENT system in Wegener's granulomatosis. Eur Arch Otorhinolaryngol. 2011 May;268(5):733-9.
Measurement of damage in systemic vasculitis: a comparison of the Vasculitis Damage Index with the Combined Damage Assessment Index. Ann Rheum Dis. 2011 Jan;70(1):80-5.
Cardiovascular involvement in primary systemic vasculitis. Best Pract Res Clin Rheumatol. 2009 Jun;23(3):419-28.
Refractory urticarial vasculitis responsive to anti-B-cell therapy. Br J Dermatol. 2009 Feb;160(2):470-2.
Modification and validation of the Birmingham Vasculitis Activity Score (version 3). Ann Rheum Dis. 2009 Dec;68(12):1827-32.
EULAR recommendations for the management of primary small and medium vessel vasculitis. Ann Rheum Dis. 2009 Mar;68(3):310-7.
EULAR recommendations for the management of large vessel vasculitis. Ann Rheum Dis. 2009 Mar;68(3):318-23.
Disease-specific quality indicators, guidelines, and outcome measures in vasculitis. Clin Exp Rheumatol. 2007 Nov-Dec;25(6 Suppl
Update on the use of biologics in primary systemic vasculitides. Expert Rev Clin Immunol. 2007 Nov;3(6):901-11.
Outcomes from studies of antineutrophil cytoplasm antibody associated vasculitis: a systematic review by the European League Against Rheumatism systemic vasculitis task force. Ann Rheum Dis. 2008 Jul;67(7):1004-10.
Courses offered to GPs
I am regularly invited to lecture at the GP education courses held by the Norfolk and Norwich Institute for Medical Education.
- MBBS Shri M P Shah Medical College, Saurashtra University 1996
- MD Shri M P Shah Medical College, Saurashtra University 1998
- MRCP (UK) Royal College of Physicians 2002
- CCT (Rheum) Postgraduate Medical Education and Training Board 2008
- MSc Green Templeton College, University of Oxford 2009
- FRCP (Edin) Royal College of Physicians of Edinburgh 2010
- FRCP (Lon) Royal College of Physicians 2015
Reference number 5203280
Professional bodies (positions held - last 3 yrs)
- Consultant Rheumatologist Norfolk and Norwich University Hospital 2009
- MRCP Part 2 Exam Board Member Federation of Royal College of Physicians 2009
- Regional Chair for East of England British Society for Rheumatology 2014
- Regional Specialty Advisor for Rheumatology Royal College of Physicians 2014
- Honorary Assistant Secretary British Society for Rheumatology 2015
- Secretary East Anglia Rheumatology Society 2014
Details of entry to specialist register
- Rheumatology, 2008
Affiliations / memberships
British Society for Rheumatology
European Vasculitis Society
Royal College of Physicians of Edinburgh
Royal College of Physicians of London
American College of Rheumatology
Royal Society of Medicine
- Global Clinic Norwich, NR4 7TY
- 16:00 - 20:00
- 01603 813681
Post treatment communication
Following treatment of a Bupa member, I will communicate with GPs in line with Department of Health, GMC and appropriate professional bodies guidelines.
In the event of an urgent query following treatment, Bupa members should use the following contact details